Expected to Drive Revenue Growth in 2019
TAMPA, FL, Feb. 25, 2019 (GLOBE NEWSWIRE) -- February 25, 2019 – Trxade Group, Inc. (OTCQB: TRXD) (“Trxade” or the “Company”), an integrated drug purchasing and delivery platform, announced today the successful launch of its MSO Pharmacy Network, via its SyncHealth joint venture. In addition, Trxade’s network of independent retail pharmacies has reached a significant milestone by surpassing 10,000 members, which is nearly 40% of US Independent pharmacists purchase prescription drugs through the Trxade B-B platform and increase both price visibility and secure additional profit.
Combining technology with services Trxade Managed Services Organization (“TrxadeMSO”) enables its member network of independent retail pharmacies acquire patients, process and deliver or ship orders to patients ensuring timely and comprehensive medication fulfillment. TrxadeMSO’s AI software predefines and continuously monitors the best-suited pharmacy services relevant to the patient needs to further ensure appropriate medication coverage for patients based on location, custom services, payor coverage, and medication access/inventory. This will save significant time and enhance patient centric care by clinician practices by creating efficiency and enhanced workflow management in script processing, reporting and fulfillment.
TrxadeMSO features:
- Flexibility. Agnostic platform for patient script delivery allowing the clinicians flexibility on how they deliver their scripts.
- Integration. Patient-centric integration technology allows the patient to choose delivery method and pay copay directly from their smart phone or computer.
- Reporting. Daily reporting for physicians to verify which medications were dispensed by appointed pharmacy ensuring improved medical reporting and adherence.
TrxadeMSO features to be made available soon:
- Telemedicine. Integration of telemedicine and MTM on patient-centric app to allow for more efficient patient care and improved medication adherence/management.
- Rx Manager. Electronic and Interactive Script generation portal/app to provide easier script management by clinician.
For more information, please visit: https://www.trxademso.com.
Trxade, a leader in the pharmaceutical e-commerce marketplace providing thousands of independent pharmacies access to low-cost medication pricing from a myriad of wholesale distributors, is expanding its services to further fulfill its vision and commitment to independent pharmacies nationally. Via its proprietary patient-centric E-HUB technology and affiliate channel partner relationships, Trxade now provides workflow technology solutions that generate new business to independent pharmacies while still providing low-cost access to medications resulting in increased revenues, enhanced margins and improved efficiency for pharmacies. The technology will revolutionize the script fulfillment process from inception to fulfillment optimizing patient’s access to their medications.
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (OTCQB: TRXD) is an integrated drug purchasing and delivery solutions company with a platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. Founded in 2010, Trxade Group currently operates the trading platform with 10,000 registered members. For additional information, please visit us at http://www.trxadegroup.com, http://www.trxade.com, http://www.delivmeds.com, https://www.trxademso.com.
Forward-Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The company undertakes no duty to update forward-looking statements.
Investors Contact:
Hayden IR
hart@haydenir.com
(917) 658-7878